Skip to main content



Dr. Ayed Ayed is board-certified in medical oncology, hematology, and internal medicine and practices at our Riverside and Northside locations. Dr. Ayed originally grew up in Palestine and received his Doctor of Medicine degree from the University of Jordan.

His first home in the United States was Gainesville, FL, where he lived for three years while completing his residency at the University of Florida. After completing his fellowship at the Mayo Clinic in Rochester, MN, Dr. Ayed returned to the region he fell in love with during his residency: North Florida.

While in high school, Dr. Ayed’s uncle was diagnosed with cancer. “His experience showed me how inadequate control of symptoms and lack of information can lead to anxiety and suffering,” he shares. This experience, combined with his love of science and biology, led him to a career in medicine and oncology, and taught him invaluable ways to assist patients. “Through witnessing my uncle’s experience, I learned that good communication and symptom management are paramount. This is something I try to emphasize with all of my patients,” he says. Dr. Ayed further adds, “my philosophy when it comes to helping patients is that keeping them well-informed results in patients who are more empowered and confident in their treatment plan.”

Dr. Ayed loves that his jobs offers him the opportunity of finding joy through service. “Serving my patients, colleagues, and community is my greatest privilege,” he says.

In his free time, Dr. Ayed enjoys vegetarian cooking, gardening, spending time with friends and loved ones, and being in nature doing activities such as hiking and kayaking.

Curriculum Vitae


Internal Medicine
Medical Oncology


American Medical Association
American Society of Clinical Oncology
American Society of Hematology
Mayo Clinic Alumni Association
Florida Medical Association


Mayo Clinic, Rochester


University of Florida


Palestine Medical Center


University of Jordan
Doctor of Medicine


University of Florida health Customer Service Key Award
University of Jordan Award for Academic Distinction


Leukemia Research
Relationship of serum imatinib trough level and response in CML patients: long term follow-up
American Journal of Clinical Pathology
Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors.
Critical Reviews in Oncology/Hematology
Immunotherapy for multiple myeloma: Current status and future directions
American Journal of Hematology
Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated with Dose-Adjusted EPOCH plus Rituximab.
Leukemia Lymphoma
Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy.
Journal of Experimental Medicine
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.
American Journal of Hematology
Ruxolitinib as first-line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience
Blood Cancer Journal
CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies.